4basebio announces lease of an innovation hub and manufacturing facility in Cambridge, UK
Posted:
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces a significant expansion into a new innovation hub and manufacturing facility in Cambridge, UK, supporting growing demand for research and high-quality grade manufacturing of synthetic DNA for gene and cell therapies, mRNA vaccines, genome editing, or DNA vaccines.
GIANT Health is delighted to welcome CareLoop to GIANT Health 2026 as part of the NHS Innovation Accelerator (NIA) Pavilion, where the team will demonstrate how remote monitoring is helping people living with severe mental illness remain well in their…
GIANT Health is delighted to welcome RealBirth to GIANT Health 2026, where the team will showcase how digital innovation is helping transform antenatal education and support more equitable maternity care across the NHS.
Access to high-quality antenatal education plays a…